Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00956800 · ClinicalTrials.gov registry record · NA

Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software

A NA study of Diabetes, sponsored by Columbus Research Foundation.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT00956800: Completed NA study of Diabetes, sponsored by Columbus Research Foundation.

NCT00956800 is a NA study of Diabetes that has completed, run by Columbus Research Foundation. The registered enrollment target is 100 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00956800, a NA study of Diabetes, has completed, sponsored by Columbus Research Foundation.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if providing some care to diabetic patients remotely, using Accuchek 360 yields at least the same clinical results for their diabetes care, according to existing guidelines, as providing all care to patients in person.

Conditions Studied

Interventions

  • OTHER Accu-Chek 360 software
  • OTHER Normal care

Study Locations (1)

Georgia

  • Columbus Research Foundation - Columbus

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-09
Est. Completion 2011-06
Phase NA
Columbus Research Foundation

1 total trials

What the finished NCT00956800 record still lists

NCT00956800 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Accu-Chek 360 software is the first listed.

NCT00956800 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00956800 about?

NCT00956800 is a clinical study titled "Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software". The purpose of this study is to determine if providing some care to diabetic patients remotely, using Accuchek 360 yields at least the same clinical results for their diabetes care, according to existing guidelines, as providing all care to patients in person.

What is the current status of trial NCT00956800?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2009-09. Estimated completion is 2011-06.

What conditions does trial NCT00956800 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT00956800?

The interventions under investigation include: Accu-Chek 360 software (OTHER), Normal care (OTHER).

Who is sponsoring clinical trial NCT00956800?

This trial is sponsored by Columbus Research Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00956800 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00956800's enrollment target sits among peer trials

100 191st of 338 higher than 144 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00956800, the US trial registry maintained by the National Library of Medicine. NCT00956800 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.